The Europe Anti Snoring Devices market is anticipated to add to more than USD 350 Million by 2026-31.

  • Historical Period: 2020-2024
  • Base Year: 2025
  • Forecast Period: 2026-2031
  • Largest Market: Germany
  • Fastest Market: Spain
  • Format: PDF & Excel
Featured Companies
  • 1 . Koninklijke Philips
  • 2 . LivaNova PLC
  • 3 . Fisher & Paykel Healthcare Corporation Limited
  • 4 . SomnoMed Inc
  • 5 . Medtronic plc
  • 6 . Meditas Ltd
  • More...

Anti-Snoring Devices Market Analysis

The historical connection between the use of anti-snoring devices in Europe and the established sleep-medicine systems in the region shows a persistent focus on clinical oversight, collaborative evaluation, and regulated home-care protocols. In many parts of Europe, national health plans have incorporated sleep-disordered breathing, emphasizing the importance of early diagnosis, referral to specialists, and interventions based on evidence. This has reframed the role of anti-snoring products, viewing them not just as wellness s but as vital elements of a preventive health care system. Devices like oral appliances and nasal dilators must conform to strict technical standards, which include precise biomechanics, effective airflow management, and adherence to established conformity regulations. Standards also frequently encompass material safety, cleanliness, and traceability of documentation, prompting manufacturers to invest deeply in research that backs ergonomic designs and durability over time. Advances in technologies like digital bite-mapping, intraoral scanning, and adjustable mechanisms for mandibular advancement highlight Europe’s commitment to customization and consistent clinical results. The impact of local medical-device regulations, particularly the Medical Device Regulation MDR, has influenced choices of materials, labeling methods, and performance accountability. This regulatory framework promotes transparency in how devices function, clarity in their risk classification, and rigorous monitoring after they hit the market. Thus, the anti-snoring sector in Europe is characterized by an ongoing interaction between clinical standards, tailored patient experiences, and accountability to regulatory bodies. According to the research report, " Europe Anti Snoring Devices Market Research Report, 2031," published by Actual Market Research, the Europe Anti Snoring Devices market is anticipated to add to more than USD 350 Million by 2026-31. The market for anti-snoring devices in Europe is enhanced by a valuation that benefits from the region's commitment to clinical proof, recommendations from healthcare professionals, and a deep awareness among the public regarding sleep health challenges.

Trends in adoption are influenced by the preference of patients for solutions backed by medical expertise, along with the rise of multidisciplinary sleep clinics that combine diagnostics with personalized device therapies. Recent advancements like re-certified oral appliance systems, digitally adjustable advancement devices, and improved nasal-breathing solutions have gained traction as suppliers meet MDR requirements. While these re-certification processes can be demanding, they have increased the reliability of devices and fostered investment in extensive testing, research on long-term outcomes, and development of advanced materials. Leading vendors in the region set themselves apart by providing evidence-based marketing, collaborating with dental-sleep experts, and utilizing more digital workflow tools such as intraoral scanners and remote compliance monitoring. As consumers in Europe place greater importance on professional fitting, comfort, and reliable quality assurance, manufacturers are progressively focusing on high-end products that are clinically supervised. Significant opportunities in the area include growing interest in tailored oral appliances, initiatives for the aging population that emphasize sleep and respiratory well-being, and the availability of more insurance or reimbursement options for clinically supported treatments. .

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample
Report Sample Preview

Market Dynamic

Market Drivers

• Increasing Demand for Clinically Proven and Safety-Approved Sleep Products: The demand for anti-snoring devices in Europe is significantly fueled by a growing interest in products that are clinically proven and safety-approved. Consumers in this area prioritize devices that carry the CE mark due to the rigorous testing, durability standards, and compliance with safety regulations associated with them. This confidence boosts the use of these alternatives among those looking for non-invasive options before exploring medical treatments. Public health campaigns that focus on addressing sleep problems in their early stages further promote this trend. Thus, manufacturers with evidence from clinical studies and clear validation processes are gaining considerable popularity.

• Increasing Recognition of Sleep Quality as Essential for Workplace Productivity: Workplaces across Europe are placing greater emphasis on sleep quality as an integral aspect of employee health, influencing workers to manage snoring and mild airway concerns. Company wellness programs, informative campaigns, and health initiatives focusing on productivity have underscored how poor sleep affects performance and mental sharpness. Consequently, numerous adults are looking for straightforward anti-snoring solutions without navigating complicated clinical procedures. Retail pharmacies and online health shops are helping to drive this trend by providing certified devices that meet workplace wellness needs. Market Challenges

• Gradual Acceptance of Digital Sleep Technologies in Specific Age Groups: In spite of Europe’s well-organized healthcare system, the adoption of digital anti-snoring devices is progressing slowly among certain age demographics, especially older individuals who tend to favor conventional or non-digital options. This reluctance restricts the use of wearable devices linked to apps and algorithm-driven oral products. Differences in digital proficiency across various population groups also affect adoption rates. Without targeted education and simpler interfaces, smart snoring products find it difficult to achieve widespread acceptance. Manufacturers need to merge innovative features with designs that are easy to use to cater to all age categories.

• Financial Strain of Regulatory Compliance Under MDR Hindering Innovation Pace: The Medical Device Regulation MDR framework in Europe enforces strict guidelines regarding documentation, risk categorization, biocompatibility assessments, and performance validation. Although these regulations improve safety, they also considerably raise development costs and delay certification for manufacturers. Smaller enterprises struggle to quickly launch new products, leading to prolonged innovation timelines. This situation complicates the introduction of cutting-edge technologies such as sensor-integrated oral devices or AI-driven positional trainers. As compliance requirements grow more stringent, businesses must redirect more resources to regulatory compliance, limiting their flexibility and responsiveness to the market. Market Trends

• Increase in Environmentally Friendly and Reusable Designs for Anti-Snoring Devices: Europe is experiencing a significant movement towards environmentally friendly anti-snoring solutions that utilize recyclable materials, components that can be reused, and eco-conscious packaging that minimizes waste. Producers are updating their items to meet the sustainability demands of the area, using soft, strong, and eco-friendly materials. This movement particularly resonates with shoppers in markets that emphasize environmental accountability in health-related products. Preferences are shifting towards reusable nasal dilators, flexible oral devices, and durable EPAP valves, as opposed to single-use options. The regional emphasis on sustainability is transforming product design and marketing strategies within the anti-snoring sector.

• Rising Popularity of 3D-Printed, Tailor-Made Oral Devices: Europe is emerging as a key center for 3D-printed, personalized oral devices that provide better comfort and support long-term use. Utilizing digital impressions and state-of-the-art scanning methods allows for highly tailored mandibular appliances that fit precisely. This technique reduces fitting mistakes and increases comfort for users, which are essential for ongoing use. Dental sleep clinics in the region are progressively adopting digital production processes. As customization becomes a key feature in Europe's sleep appliance industry, 3D printing is anticipated to become a leading force in the forthcoming evolution of sleep health technology.
Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Manmayi Raval
Manmayi Raval

Analyst

Anti-Snoring DevicesSegmentation

By product Mandibular Advancement Devices (MADs)
Tongue Stabilizing Devices (TSDs)
Continuous Positive Airway Pressure (CPAP) Devices
Nasal Devices
Positional Therapy Devices
Expiratory Positive Airway Pressure (EPAP) Devices
Others
By Type of Snoring/Indication Primary Snoring (Simple Snoring)
Obstructive Sleep Apnea (OSA)-Related Snoring
By Distribution Channel Retail Pharmacies & Drug Stores
Hospital & Sleep Clinics
E-commerce/Online Platforms (A rapidly growing segment due to DTC brands)
Other (Hypermarkets/Supermarkets, Specialty Stores)
By End-User Home Care Settings/Individuals (The dominant segment for OTC devices)
Sleep Laboratories & Clinics
Hospitals
Europe North America
Europe
Asia-Pacific
South America
MEA



Positional therapy devices are experiencing the quickest growth in Europe as they match the region's inclination toward conservative, non-invasive, evidence-based methods for managing snoring that fit into prevention-centered healthcare strategies.

In Europe, devices for positional therapy are quickly becoming the leading segment in the anti-snoring market. This growth is driven by a mix of clinical practices, behavioral approaches, and regulations that promote low-risk and non-invasive options. Practitioners in European sleep medicine advocate for gradual, conservative treatment methods, urging doctors to suggest positional therapy for individuals whose snoring or mild obstructive sleep apnea is significantly influenced by their sleeping position. This strategy aligns seamlessly with Europe’s healthcare approach, which focuses on prevention and aims to alleviate future healthcare demands through early and less invasive interventions. Positional therapy stands out since it circumvents the discomfort and fitting complications typically linked to oral devices and CPAP machines. Recent advancements have upgraded standard positional tools into intelligent, sensor-equipped devices that provide gentle vibrations, guiding users to sleep on their sides without interruption. These innovations, along with ergonomic designs and apps for tracking compliance, have enhanced the patient experience and shown strong adherence in clinical studies. European regulatory standards under the MDR favor clear performance metrics and safety documentation, and manufacturers of positional devices have efficiently fulfilled these requirements due to their relatively straightforward mechanical and electronic components. Furthermore, the aging populace and greater awareness of sleep hygiene have created an increased need for non-medical home care solutions that individuals can manage on their own. Many patients, as well as healthcare providers, prefer to try positional therapy prior to resorting to mandibular devices or CPAP, thus speeding up its acceptance. Europe’s emphasis on minimally invasive, evidence-backed, and user-centric treatment options has made positional therapy devices the fastest-growing category of anti-snoring products in the region.

OSA-related snoring is prevalent and grows quickly in Europe since clinical guidelines, evidence requirements mandated by MDR, and healthcare systems focused on prevention emphasize treating OSA as the main medical reason behind snoring.

In Europe, snoring associated with OSA represents the most significant and rapidly expanding category in the anti-snoring devices industry, largely due to the well-organized, preventive healthcare frameworks in the region along with a strong focus on clinical validation and safety. Protocols related to sleep medicine in Europe identify snoring as a possible sign of OSA, which leads doctors to place a high importance on thorough assessments and diagnostic processes that involve polysomnography, home evaluations, and ongoing symptom tracking. Given that OSA has major implications for cardiovascular health, workplace effectiveness, and quality of life, treatment options heavily lean towards scientifically supported devices, including CPAP machines, devices that advance the jaw, and therapeutic tools that track position using sensors. The EU Medical Device Regulation MDR further supports this trend by mandating evidence of clinical performance, validation of biocompatibility, durability assessment, and clear labeling of devices standards that are more readily fulfilled by OSA-specific treatments compared to basic over-the-counter solutions for snoring. The aging demographic in Europe and heightened awareness of respiratory and sleep-related health issues contribute to increasing OSA diagnosis rates, while public health initiatives stress the importance of early intervention and long-term adherence over temporary symptom relief. Innovations in fitting digital oral appliances, providing telemonitoring for CPAP usage, and creating ergonomic, patient-focused designs are driving market growth. Growing partnerships among dentists, ENT specialists, lung specialists, and sleep experts ensure that complaints about snoring are directed toward diagnostic paths that focus on OSA.

E-commerce leads in Europe due to consumers depending on certified online stores for accessing regulated, CE-marked anti-snoring devices with clear information and trustworthy sources.

In Europe, the e-commerce channel stands out as the most significant and rapidly growing avenue for distributing devices designed to combat snoring. This trend has been fueled by consumers’ strong preference for purchasing regulated and CE-marked health solutions online, where they can find a wealth of reliable information. The anti-snoring market particularly thrives in this environment, as buyers now have the ability to evaluate products thoroughly, gathering essential details about effectiveness and safety before making a purchase. Online marketplaces offer essential transparency, allowing consumers to compare different devices backed by verified scientific evidence, ensuring they make informed choices. As many individuals seek solutions with minimal hassle, e-commerce provides a convenient path to obtaining these devices without navigating through medical facilities. The region's regulatory framework further supports the online marketplace by establishing clear standards for product quality and sourcing. With many reputable brands gaining a strong online presence, consumers feel confident about making purchases through trusted platforms. The shifting focus towards digital health technologies aligns well with the growing trend of online consultations and telehealth services. Such platforms frequently include links to recommended anti-snoring products, streamlining the purchasing process for users. The influence of online reviews and customer feedback also plays a crucial role in shaping purchase decisions, creating a culture of trust. With effective shipping logistics, quick deliveries, and straightforward return policies allowing for easy product trials, European consumers experience enhanced shopping convenience. The combination of regulations, consumer confidence, and improved online access makes e-commerce the leading and most effective channel for acquiring anti-snoring devices across Europe.

Home care settings see rapid growth and establish a strong presence in Europe because prevention-focused healthcare systems and MDR-approved consumer products facilitate safe, non-clinical management of snoring at home.

Within Europe, individuals and home care environments represent the largest and quickest expanding user category in the market for anti-snoring devices due to a strong cultural emphasis on accessible, preventive, and non-invasive care that can be provided at home. European healthcare systems regularly advocate for early intervention and self-management regarding common health issues, urging people to tackle snoring problems before they turn into more serious health concerns. Anti-snoring devices, which include a variety of solutions such as personalized oral appliances and innovative positional therapy options, are increasingly crafted for safe and effective home usage. These products come equipped with clear labeling that complies with MDR regulations, performance data that has been validated, and user-friendly instructions that enhance consumer trust. The rise of pharmacy chains, online medical sellers, and regulated e-commerce platforms allows for straightforward access to clinically appropriate snoring remedies without the necessity for direct hospital care. Europeans show significant awareness of the importance of sleep quality and well-being, which encourages people to proactively utilize anti-snoring devices, particularly when mild symptoms do not yet require specialized medical attention. The increasing availability of digital bite-mapping, ergonomic kits for oral appliance fitting, app-connected positional therapy tools, and user-friendly CPAP systems for home use has made at-home treatment more feasible and attractive. Furthermore, with the aging population in Europe, there is a preference for solutions that minimize the need for frequent clinical visits while still providing tangible improvements in sleep quality. Remote monitoring technologies, teleconsultations, and hybrid models of sleep care further support the trend toward managing these conditions at home.

Anti-Snoring Devices Market Regional Insights


Germany holds the top position in Europe’s anti-snoring devices market thanks to its organized healthcare system, strong foundation in medical device production, high rates of diagnosis, and a well-established culture of clinical validation.

Germany is the foremost nation in Europe for anti-snoring devices due to its systematic healthcare system, tightly controlled medical-device regulations, and effective blend of sleep medicine within public health approaches. The nation ranks among the highest in Europe for the concentration of sleep labs and certified sleep specialists, facilitating the prompt identification of snoring and sleep-related breathing issues. This clinical expertise promotes the broad prescription and monitored usage of CPAP machines, devices for advancing the jaw, and technologies for positional therapy. Germany’s public health insurance framework enhances adoption, as devices deemed medically necessary for snoring associated with OSA frequently receive reimbursement, which fosters patient adherence and ongoing use. Furthermore, Germany stands out as a key center for engineering and manufacturing of medical devices, featuring numerous firms that focus on respiratory care, dental-sleep products, ergonomic solutions, and precisely crafted oral devices. With MDR regulations elevating requirements for evidence, effectiveness, and safety, German manufacturers thrive because of their well-established R& D resources, stringent quality controls, and strong partnerships with clinical organizations. German consumers possess a notably high level of awareness regarding sleep health, supported by preventive care initiatives and public health programs that promote prompt assessment of snoring symptoms. Pharmacies, specialized clinics, and regulated online platforms offer reliable, safe access to both clinically approved devices and consumer-friendly snoring aids. Population trends, such as an older demographic and increasing sleep issues tied to lifestyle choices, further boost demand. Germany’s clinical expertise, regulatory compliance, research advancements, manufacturing preeminence, and patient-centered healthcare approach establish it as Europe’s most significant and powerful market for anti-snoring devices.

Companies Mentioned

  • 1 . Koninklijke Philips
  • 2 . LivaNova PLC
  • 3 . Fisher & Paykel Healthcare Corporation Limited
  • 4 . SomnoMed Inc
  • 5 . Medtronic plc
  • 6 . Meditas Ltd
  • 7 . ResMed
  • 8 . GlaxoSmithKline plc.
  • 9 . ZQuiet LLC
  • 10 . Mpowrx
  • 11 . Nyxoah SA
  • 12 . Whole You, Inc
Company mentioned

Table of Contents

  • Table 1: Global Anti Snoring Devices Market Snapshot, By Segmentation (2024 & 2031) (in USD Billion)
  • Table 2: Influencing Factors for Anti Snoring Devices Market, 2025
  • Table 3: Top 10 Counties Economic Snapshot 2022
  • Table 4: Economic Snapshot of Other Prominent Countries 2022
  • Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
  • Table 6: Europe Anti Snoring Devices Market Size and Forecast, By Product (2020 to 2031F) (In USD Billion)
  • Table 7: Europe Anti Snoring Devices Market Size and Forecast, By Type of Snoring/Indication (2020 to 2031F) (In USD Billion)
  • Table 8: Europe Anti Snoring Devices Market Size and Forecast, By Distribution Channel (2020 to 2031F) (In USD Billion)
  • Table 9: Europe Anti Snoring Devices Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
  • Table 10: Germnay Anti Snoring Devices Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
  • Table 11: Germnay Anti Snoring Devices Market Size and Forecast By Type of Snoring/Indication (2020 to 2031F) (In USD Billion)Table 12 Germnay Anti Snoring Devices Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
  • Table 13: United Kingdom (UK) Anti Snoring Devices Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
  • Table 14: United Kingdom (UK)Anti Snoring Devices Market Size and Forecast By Type of Snoring/Indication (2020 to 2031F) (In USD Billion)
  • Table 15: United Kingdom (UK) Anti Snoring Devices Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
  • Table 16: France Anti Snoring Devices Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
  • Table 17: France Anti Snoring Devices Market Size and Forecast By Type of Snoring/Indication (2020 to 2031F) (In USD Billion)
  • Table 18: France Anti Snoring Devices Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
  • Table 19: Italy Anti Snoring Devices Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
  • Table 20: Italy Anti Snoring Devices Market Size and Forecast By Type of Snoring/Indication (2020 to 2031F) (In USD Billion)
  • Table 21: Italy Anti Snoring Devices Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
  • Table 22: Spain Anti Snoring Devices Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
  • Table 23: Spain Anti Snoring Devices Market Size and Forecast By Type of Snoring/Indication (2020 to 2031F) (In USD Billion)
  • Table 24: Spain Anti Snoring Devices Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
  • Table 25: Russia Anti Snoring Devices Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
  • Table 26: Russia Anti Snoring Devices Market Size and Forecast By Type of Snoring/Indication (2020 to 2031F) (In USD Billion)
  • Table 27: Russia Anti Snoring Devices Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
  • Table 28: Competitive Dashboard of top 5 players, 2025

  • Figure 1: Global Anti Snoring Devices Market Size (USD Billion) By Region, 2024 & 2031
  • Figure 2: Market attractiveness Index, By Region 2031
  • Figure 3: Market attractiveness Index, By Segment 2031
  • Figure 4: Europe Anti Snoring Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 5: Europe Anti Snoring Devices Market Share By Country (2025)
  • Figure 6: Germany Anti Snoring Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 7: United Kingdom (UK) Anti Snoring Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 8: France Anti Snoring Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 9: Italy Anti Snoring Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 10: Spain Anti Snoring Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 11: Russia Anti Snoring Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 12: Porter's Five Forces of Global Anti Snoring Devices Market

Anti-Snoring Devices Market Research FAQs

The coverage of anti-snoring devices by health insurance can vary depending on the country and the specific device. In general, anti-snoring devices are more likely to be covered if they are prescribed by a healthcare professional and deemed medically necessary.
There are several different types of anti-snoring devices available in Europe, including mandibular advancement devices, tongue retaining devices, nasal dilators, chin straps, and positional therapy devices.
Some anti-snoring devices require a prescription from a healthcare professional, while others can be purchased over-the-counter. It is important to consult with a healthcare professional before using any anti-snoring device.
The Europe Anti Snoring Device market refers to the industry that produces and sells devices designed to help people reduce or eliminate snoring. These devices include nasal strips, mouthpieces, chin straps, and other types of anti-snoring aids.
Snoring is a common problem that affects millions of people in Europe and around the world. It can cause sleep disturbances, daytime fatigue, and other health problems. Anti-snoring devices can help reduce or eliminate snoring, improving sleep quality and overall health.
The increasing prevalence of snoring and sleep apnea, rising awareness of the health risks associated with snoring, and growing demand for non-invasive and cost-effective snoring solutions are some of the major drivers of growth in the Europe Anti Snoring Device market.
Consumers in Europe tend to prefer environmentally friendly, reusable, and ergonomically designed products, which aligns with wider sustainability efforts.
Hospitals and sleep disorder clinics significantly influence the process, often endorsing oral appliances or CPAP alternatives in treatment regimens.
Lifestyle choices, including alcohol and tobacco use, increase the occurrence of snoring, leading to a higher demand for preventative products.
CE marking ensures compliance with safety and quality standards, serving as a crucial element for consumer trust and market entry.

Why Actual Market Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology 92%
Data Collection Techniques 97%
Our Research Team & Data Sourcing 93%
Data Science & Analytical Tools 81%
Data Visualization & Presentation Skills 86%
Project/ Report Delivery & After Sales Services 88%

Related Tags